Software Announcement: Artificial Intelligence powered iPSC confluency scanning available on Cell Metric® – extending cell therapy workflows.

CM 3.6.13.2, VIPS is 1.0.19.11075 September 2021 Announced September 2021, a new software release for Cell Metric®. Cell Metric will now support an advanced, artificial intelligence powered algorithm for iPSC confluency detection. With this package, laboratories working with VIPS™ for single iPSC seeding for cell therapy applications or other seeding approaches, can utilise the Cell Metric …

Read more Software Announcement: Artificial Intelligence powered iPSC confluency scanning available on Cell Metric® – extending cell therapy workflows.

Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization

NORWOOD, Mass., August 5, 2021 – Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the execution of a definitive agreement to acquire Solentim, a trusted global leader of solutions for the isolation and characterization of high value single cell clones in cell line development (CLD) applications. The acquisition expands …

Read more Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization

Solentim to exhibit at BioProcess International, September 20-23, Boston

Solentim, the trusted global leader in workflows for antibody and cell-based therapies, will be exhibiting at the BioProcess International, September 20-23, Boston. Come visit stand #435 where we’ll be presenting our integrated ecosystem of technologies for seeding, assurance, growth and selection. BioProcess International is billed as the the largest bioprocessing event for learning how to …

Read more Solentim to exhibit at BioProcess International, September 20-23, Boston

STUDIUS™ – A Gamechanger for Cell Line Development: New Commentary White Paper

Operating within the structure of Chemical, Manufacturing and Control (CMC), Cell Line Development (CLD) is a pivotal control strategy within the development of therapeutic antibodies. Risk-based strategies towards quality control are deeply embedded in CLD yet challenged, as are CLD scientists, on a daily basis with the burden and worry of data consolidation. Methodologies, utilised …

Read more STUDIUS™ – A Gamechanger for Cell Line Development: New Commentary White Paper

Solentim agrees exclusive distribution deal with Matrixome to supply clinical manufacturing grade laminin to cell therapy market

Bournemouth, UK, 10th June 2021 / Solentim, the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, has today announced an exclusive distribution agreement with Matrixome Inc. (Japan) for use in conjunction with Solentim’s instrumentation. Under the new agreement, Solentim will add a clinical manufacturing-grade …

Read more Solentim agrees exclusive distribution deal with Matrixome to supply clinical manufacturing grade laminin to cell therapy market